Andropause: Is the Emperor Wearing Any Clothes?

  • S. H. Tariq
  • M. T. Haren
  • M. J. Kim
  • J. E. Morley


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Matsumoto AM. Andropause: clinical implication of the decline in serum testosterone levels with aging in men. J Gerontol Med Sci 2002;57A:M76–M99.Google Scholar
  2. 2.
    Morley JE. Hormones and the aging process. J Am Geriatr Soc 2003;51(7 Suppl S):S333–S337.Google Scholar
  3. 3.
    Blazer DG. Depression in late life: review and commentary. J Gerontol Med Sci 2003;58A:249–265.Google Scholar
  4. 4.
    Haren MT, Wittert GA, Chapman IM, Coates P, Morley JE. Effect of 12-month oral testosterone on testosterone deficiency symptoms in symptomatic elderly males with low-normal gonadal status. Age & Ageing (in press).Google Scholar
  5. 5.
    Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype.J Gerontol Med Sci 2001;56A:M146–M156.Google Scholar
  6. 6.
    Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol Med Sci 2004;59A:255–263.Google Scholar
  7. 7.
    Morley JE, Perry HM III, Miller DK. Something about frailty. J Gerontol Med Sci 2002;57A:M698–M704.Google Scholar
  8. 8.
    Brown I, Renwick R, Raphael D. Frailty: constructing a common meaning, definition, and conceptual framework. Int J Rehab Res 1995;18:93–102.Google Scholar
  9. 9.
    Morley JE, Kaiser FE, Sih R, Hajjar R, Perry HM. Testosterone and frailty. Clin Geriatr Med 1997;13:685–694.Google Scholar
  10. 10.
    Morley JE, Perry HM. Androgens and women at the menopause and beyond. J Gerontol Med Sci 2003;58A:409–416.Google Scholar
  11. 11.
    Morley JE, Baumgartner RN. Cytokine-related aging process. J Gerontol Med Sci 2004;59A:924–929.Google Scholar
  12. 12.
    Cesari M, Penninx BWJH, Pahor M, Lauretani F, Corsi AM, Williams GR, Guralnik JM, Ferrucci L. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol Med Sci 2004;59A:242–248.Google Scholar
  13. 13.
    Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, Jones TH. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab 2004;89:3313–3318.Google Scholar
  14. 14.
    Lambert CP, Sullivan DH, Evans WJ. Effects of testosterone replacement and/or resistance training on interleukin-6, tumor necrosis factor alpha, and leptin in elderly men ingesting megestrol acetate: a randomized controlled trial. J Gerontol Med Sci 2003;58:165-170.Google Scholar
  15. 15.
    Horani MH, Morley JE. Hormonal fountains of youth. Clin Geriatr Med 2004;20:275–292.Google Scholar
  16. 16.
    Werner AA. The male climacteric: report of two hundred and seventy-three cases. JAMA 1946;132:188–194.Google Scholar
  17. 17.
    Asthana S, Bhasin S, Butler RN, Fillit H, Finkelstein J, Harman SM, Holstein L, Korenman SG, Matsumoto AM, Morley JE, Tsitouras P, Urban R. Masculine vitality: pros and cons of testosterone in treating the andropause. J Gerontol Med Sci 2004;461–465.Google Scholar
  18. 18.
    Snyder PJ. Hypogonadism in elderly men—what to do until the evidence comes. N Engl J Med 2004;350:440–442.Google Scholar
  19. 19.
    Morley JE, Perry III HM. Androgen deficiency in aging men: role of testosterone replacement therapy. J Lab Clin Med 2000;135:370–378.Google Scholar
  20. 20.
    Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 2001;86:724–731.Google Scholar
  21. 21.
    Morley JE, Kaiser FE, Perry III HM, Patrick P, Morley PM, Stauber PM, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 1997;46:410–413.Google Scholar
  22. 22.
    Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab.2002;87:589–598.Google Scholar
  23. 23.
    Leifke E, Gorenoi V, Wichers C, von Zur Muhlen A, von Buren E, Brabant G. Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex- hormone binding globulin levels in men: cross-sectional data from a healthy male cohort. Clin Endocrinol 2000;53:689–695.Google Scholar
  24. 24.
    Kaiser FE, Viosca SP, Morley JE, Mooradian AD, Davis SS, Korenman SG. Impotence and aging: clinical and hormonal factors. J Am Geriatr Soc 1988;36:511–519.Google Scholar
  25. 25.
    Keenan DM, Veldhuis JD. Disruption of the hypothalamic luteinizing hormone pulsing mechanism in aging men. Am J Physiol Regulatory Integrative & Comparative Physiology.2001;281:R1917–R1924.Google Scholar
  26. 26.
    Korenman SG, Morley JE, Mooradian AD, Davis SS, Kaiser FE, Silver AJ, et al. Secondary hypogonadism in older men: Its relation to impotence. J Clin Endocrinol Metab 1990;71:963–969.Google Scholar
  27. 27.
    Harman SM, Tsitouras PD. Reproductive hormones in aging men. I. Measurement of sex steroids, basal luteinizing hormone, and Leydig’s cell response to human chorionic gonadotropin. J Clin Endocrinol Metab 1980;51:35–40.Google Scholar
  28. 28.
    Veldhuis JD, Iranmanesh A, Keenan DM. Erosion of endogenous testosterone-driven negative feedback on pulsatile luteinizing hormone secretion in healthy aging men. J Clin Endocrinol Metab 2004;89:5753–5761.Google Scholar
  29. 29.
    Winters SJ, Atkinson L. Serum LH concentrations in hypogonadal men during transdermal testosterone replacement through scrotal skin: further evidence that ageing enhances testosterone negative feedback. The Testoderm Study Group. Clin Endocrinol 1997;47:314–322.Google Scholar
  30. 30.
    Tenover JS, Bremner WJ. Circadian rhythm of serum immunoreactive inhibin in young and elderly men. J Gerontol Med Sci 1991;46:M181–M184.Google Scholar
  31. 31.
    Wang C, Catlin DH, Demers LM, Starcevic B, Swerdloff RS. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 2004;89:534–543.Google Scholar
  32. 32.
    Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666–3672.Google Scholar
  33. 33.
    Morley JE, Patrick P, Perry III HM. Evaluation of assays available to measure free testosterone. Metabolism 2002;51:554–559.Google Scholar
  34. 34.
    Kelleher S, Conway AJ, Handelsman DJ. Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab 2004;89:3813–3817.Google Scholar
  35. 35.
    Riad-Fahmy D, Read GF, Walker RF, Griffiths K. Steroids in saliva for assessing endocrine function. Endocrine Reviews 1982;3:367–395.Google Scholar
  36. 36.
    Schiavi RC, Schreiner-Engel P, White D, Mandeli J. The relationship between pituitary-gonadal function and sexual behavior in healthy aging men. Psychosom Med 1991;53:363–374.Google Scholar
  37. 37.
    Davidson JM, Chen JJ, Carpo L, Gray GD, Greenleaf WJ, Catania JA. Hormonal changes and sexual function in aging men. J Clin Endocrinol Metab 1983;57:71–77.Google Scholar
  38. 38.
    Morales A, Johnston B, Heaton JP, Lundie M. Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes. J Urol 1997;157:849-854.Google Scholar
  39. 39.
    Billington CJ, Mooradian AD, Duffy L, Lange P, Morley JE. Testosterone therapy in impotent patients with normal testosterone. Clin Res 1983;31:718A.Google Scholar
  40. 40.
    Aversa A, Isidori AM, De Martino AU, Caprio M, Fabbrini E, Rocchetti March M, Frajese G, Fabbri A. Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction. Clin Endocrinol (Oxf) 2000;53:517–522.Google Scholar
  41. 41.
    Tariq SH, Haleem U, Omran ML, Kaiser FE, Perry HM, Morley JE. Erectile dysfunction: etiology and treatment in young and old patients. Clin Geriatr Med 2003;19:539–551.Google Scholar
  42. 42.
    Aversa a, Isidori AM, Spera G, Lenzi A, Fabbri A. Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol 2003;58:632–638.Google Scholar
  43. 43.
    Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to dildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urology 2004;172:658–663.Google Scholar
  44. 44.
    Aversa A, Isidori AM, Spera G, Lenzi A, Fabbri A. Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf) 2003;58:632–638.Google Scholar
  45. 45.
    Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P, Morley JE. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol Med Sci 2003;58A:618–625.Google Scholar
  46. 46.
    Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, Holmes JH, Dlewati A, Santanna J, Rosen CJ, Strom BL. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 1999;84:2647–2653.Google Scholar
  47. 47.
    Kenny AM, Prestwood KM, Gruman CA, Marcello KM, Raisz LG. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol Med Sci2001;56A:M266–M272.Google Scholar
  48. 48.
    Morley JE, Perry HM, Kaiser FE, Kraenzle D, Jerisen J, Houston K, et al. Effects of testosterone replacement therapy in older hypogonadal males: a preliminary study. J Am Geriatr Soc 1993;41:149–152.Google Scholar
  49. 49.
    Sih R, Morley JE, Kaiser FE, Perry III HM, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol 1997;82:1661–1667.Google Scholar
  50. 50.
    Bhasin S. Testosterone supplementation for aging-associated sarcopenia. J Gerontol Med Sci 2003;58A:1002–1008.Google Scholar
  51. 51.
    Ferrando AA, Sheffield-Moore M, Yeckel CW, Gilkison C, Jiang J, Achacosa A, et al. Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab 2002;282:E601–E607.Google Scholar
  52. 52.
    Bhasin S, Taylor WE, Singh R, Artaza J, Sinha-Hikim I, Jasuja R, Choi H,Gonzalez-Cadavid NF. The mechanisms of androgen effects on body composition: mesenchymal pluripotent cell as the target of androgen action. J Gerontol Med Sci 2003;58A:M1103-M1110.Google Scholar
  53. 53.
    Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ. Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Devel 1999;48:378–384.Google Scholar
  54. 54.
    Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol Med Sci 2002;57A:M772–M777.Google Scholar
  55. 55.
    Perry HM, Miller DK, Patrick P, Morley JE. Testosterone and leptin in older African-American men: relationship to age, strength, function, and season. Metab Clin Exper.2000;49:1085–1091.Google Scholar
  56. 56.
    Baumgartner RN, Waters DL, Morley JE, Patrick P, Montoya GD, Garry PJ. Age-related changes in sex hormones affect the sex difference in serum leptin independently of changes in body fat. Metabolism 1999;48:378–384.Google Scholar
  57. 57.
    Morley JE. Anorexia of aging—physiologic and patholic. Am J Clin Nutr 1997;66:760–773.Google Scholar
  58. 58.
    Shores MM, Moceri VM, Gruenewald DA, Brodkin KI, Matsumoto AM, Kivlahan DR. Low testosterone is associated with decreased function and increased mortality risk: a preliminary study of men in a geriatric rehabilitation unit. J Am Geriatr Soc 2004;52:2077-2082.Google Scholar
  59. 59.
    Bakhshi V, Elliott M, Gentili A, Godschalk M, Mulligan T. Testosterone improves rehabilitation outcomes in ill older men. J Am Geriatr Soc 2000;48:550–553.Google Scholar
  60. 60.
    Amory JK, Chansky HA, Chansky KL, Camuso MR, Hoey CT, Anawalt BD, Matsumoto AM, Bremner WJ. Preoperative supraphysiological testosterone in older men undergoing knee replacement surgery. J Am Geriatr Soc 2002;50:1698–1701.Google Scholar
  61. 61.
    Haren MT, Wittert GA, Chapman IM, Coates P, Morley JE. Effect of oral testosterone undecanoate on visuospatial cognition, mood and quality of life in elderly men with low-normal gonadal status. Maturitas (in Press).Google Scholar
  62. 62.
    Reddy P, White CM, Dunn AB, Moyna NM, Thompson PD. The effect of testosterone on health-related quality of life in elderly males—a pilot study. J Clin Pharm Therapeutics 2000;25:421–426.Google Scholar
  63. 63.
    Kenny AM, Bellantonio S, Gruman CA, Acosta RD, Prestwood KM. Effects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable testosterone levels. J Gerontol Med Sci 2002;57A:M321–M325.Google Scholar
  64. 64.
    Seidman SN, Spatz E, Rizzo C, Roose SP. Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial. J Clin Psychiatr2001b;62:406–412.Google Scholar
  65. 65.
    English KM, Steeds RP, Jones TH, Diver MJ, Channer KS. Low-dose trandermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation 2000;102:1906–1911.Google Scholar
  66. 66.
    Falahati-Nini A, Riggs BL, Atkinson EJ, O’Fallon WM, Eastell R, Khosla S. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 2000;106:1553–1560.Google Scholar
  67. 67.
    Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Holmes JH, Dlewati A, Staley J, Santanna J, Kapoor SC, Attie MF, Haddad JG Jr, Strom BL. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 1999;84:1966–1972.Google Scholar
  68. 68.
    Amory JK, Watts NB, Easley KA, Sutton PR, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab.2004;89:503–510.Google Scholar
  69. 69.
    Abbasi AA, Rudman D, Wilson CR, Drinka PJ, Basu SN, Mattson DE, Richardson TJ. Observations on nursing home residents with a history of hip fracture. Am J Med Sci 1995;310:229–234.Google Scholar
  70. 70.
    Jackson JA, Riggs MW, Spiekerman AM. Testosterone deficiency as a risk factor for hip fractures in men: a case-control study. Am J Med Sci 1992;304:4–8.Google Scholar
  71. 71.
    Stanley HL, Schmitt BP, Poses RM, Deiss WP. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? J Am Geriatr Soc 1991;39:766–771.Google Scholar
  72. 72.
    Kenny AM, Fabregas G, Song C, Biskup B, Bellantonio S. Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss. J Gerontol Med Sci 2004;59A:75–78.Google Scholar
  73. 73.
    Janowsky JS, Chavez B, Orwoll E. Sex steroids modify working memory. J Cogn Neurosci.2000;12:407–414.Google Scholar
  74. 74.
    Cherrier MM, Asthana S, Plymate S, Baker L, Matsumoto AM, Peskind E, et al. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology 2001;57:80-88.Google Scholar
  75. 75.
    Janowsky JS, Oviatt SK, Orwoll ES. Testosterone influences spatial cognition in older men. Behav Neurosci 1994;108:325–332.Google Scholar
  76. 76.
    Morley JE, Kaiser F, Raum WJ, Perry III HM, Flood JF, Jensen J, et al. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proc Natl Acad Sci USA 1997;94:7537–7542.Google Scholar
  77. 77.
    Barrett-Conner E, Goodman Gruen D, Patay B. Endogenous sex hormones and cognitive function in older men.J Clin Endocrinol Metab 1999;84:3681–3685.Google Scholar
  78. 78.
    Flood JF, Morley JE. Learning and memory in the SAMP8 mouse.Neurosci Biobehav Reviews.1998;22:1–20.Google Scholar
  79. 79.
    Flood JF, Farr SA, Kaiser FE, Laregina M, Morley JE. Age-related decrease of plasma testosterone in SAMP8 mice—replacement improves age-related impairment of learning and memory. Physiol Behav 1995;57:669–673.Google Scholar
  80. 80.
    Morley JE, Kumar VB, Barnardo AE, Farr SA, Uezu K, Tumosa N, Flood JF. Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides 2000;21:1761–1767.Google Scholar
  81. 81.
    Pike CJ. Testosterone attenuates beta-amyloid toxicity in cultured hippocampal neurons. Brain Research 2001;919:160–165.Google Scholar
  82. 82.
    Moffat SD, Zonderman AB, Metter EJ, Kawas C, Blackman MR, Harman SM, Resnick SM. Free testosterone and risk for Alzheimer disease in older men. Neurology 2004;62:188–193.Google Scholar
  83. 83.
    Hogervorst E, Williams J, Budge M, Barnetson L, Bombrinck M, Smith AD. Serum total testosterone is lower in men with Alzheimer’s disease. Neuroendocrinology Letters 2001;22:163–168.Google Scholar
  84. 84.
    English KM, Mandour O, Steeds RP, Diver MJ, Jones TH, Channer KS. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J 2000;21:890–894.Google Scholar
  85. 85.
    Muller M, van den Beld AW, Bots ML, Grobbee DE, Lamberts SWJ, van der Schouw YT. Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation 2004;109:2074–2079.Google Scholar
  86. 86.
    Webb CM, Adamson DL, de Zeigler D, Collins P. Effect of acute testosterone on myocardial ischaemia in mean with coronary artery disease. Am J Cardiol 1999;83:437–439.Google Scholar
  87. 87.
    Ong PJ, Patrizi G, Chong WC, Webb CM, Hayward CS, Collins P. Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease. Am J Cardiol 2000;85:269–272.Google Scholar
  88. 88.
    English KM, Steeds RP, Jones TH, Diver MJ, Channer KS. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation 2000;102:1906–1911.Google Scholar
  89. 89.
    Hajjar RR, Kaiser FE, Morley JE. Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. J Clin Endocrinol Metab 1997;82:3793–3796.Google Scholar
  90. 90.
    Hartnell J, Korenman SG, Viosca SP. Results of testosterone enanthate therapy in older men. Proc 72nd Ann Meeting Endocrine Soc 1990;428.Google Scholar
  91. 91.
    Cesari M, Penninx BW, Lauretani F, Russo CR, Carter C, Bandinelli S, Atkinson H, Onder G, Pahor M, Ferrucci L. Hemoglobin levels and skeletal muscles: results from the InCHIANTI study. J Gerontol Med Sci 2004;59A:249–254.Google Scholar
  92. 92.
    Thomas DR. Anemia and quality of life: unrecognized and undertreated. J Gerontol Med Sci 2004;59A:238–241.Google Scholar
  93. 93.
    Kenny AM, Prestwood KM, Gruman CA, Fabregas G, Biskkup B, Mansoor G. Effects of transdermal testosterone on lipids and vascular reactivity in older men with low bioavailable testosterone levels. J Gerontol Med Sci 2002;57A:M460–M465.Google Scholar
  94. 94.
    Snyder PJ, Peachey H, Berlin JA, Rader D, Usher D, Loh L, Hannoush P, Delwati A, Holmes JH, Santanna J, Strom BL. Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age. Am J Med 2001;111:255–260.Google Scholar
  95. 95.
    Joseph MA. et al. Relationship of serum sex-steroid hormones and prostate volume in African American men. Prostate 2002;53:322–329.Google Scholar
  96. 96.
    Meikle A. W. et al. Effects of age and sex hormones on transition and peripheral zone volumes of prostate and benign prostatic hyperplasia in twins. J Clin Endocrinol Metab 1997;82:571–575.Google Scholar
  97. 97.
    Morley JE. Testosterone treatment in older men: effects on the prostate. Endocrine Practice 2000;6:218–221.Google Scholar
  98. 98.
    Gooren LJ. A ten-year safety study of the oral androgen testosterone andecanoate. J Androl 1994;15:212–215.Google Scholar
  99. 99.
    Fowler Jr, JE, Whitmore Jr, WF. The response of metastic adenocardinoma of prostate to exogenous testosterone. J Urol 1981;126:372–375.Google Scholar
  100. 100.
    Schatzl G, Madersbacher S, Thurridl T, Waldmuller J, Kramer G, Haitel A, et al. High-grade prostate cancer is associated with low serum testosterone levels. Prostate 2001;67:52–58.Google Scholar
  101. 101.
    Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000;49:1239–1242.Google Scholar
  102. 102.
    Heineman AJ, Zimmermann J, Vermeulen A, Thiel C. A new aging male’s symptoms (AMS) rating scale. The Aging Male 1999;2:105–114.Google Scholar
  103. 103.
    Tancredi A, Reginster JY, Schleich F, Pire G, Maassen P, Luyckx F, Legros JJ. Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers. Eur J Endocrinol 2004;151:355–360.Google Scholar
  104. 104.
    Smith KW, Feldman HA, McKinlay JB. Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men. Clin Endocrinol 2000;53:703–711.Google Scholar
  105. 105.
    O’Donnell AB, Araujo AB, McKinlay JB. The health of normally aging men: the Massachusetts Male Aging Study (1987-2004). Experimental Gerontology 2004;39:975–984.Google Scholar
  106. 106.
    Morley JE, Perry HM 3rd. Andropause: an old concept in new clothing. Clin Geriatr Med 2003;19:507–528.Google Scholar
  107. 107.
    Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Berman N, Hull L, Swerdloff RS. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 2004;89:2083–2098.Google Scholar
  108. 108.
    Marbury T, Hamill E, Bachand R, Sebree T, Smith T. Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim®, compared to AndroGel®. Biopharmaceutics & Drug Disposition 2003;24:115–120.Google Scholar
  109. 109.
    Wang C, Swerdloff R, Kipnes M, Matsumoto AM, Dobs AS, Cunningham G, Katznelson L, Weber TJ, Friedman TC, Snyder P, Levine HL. New testosterone buccal system (striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men. J Clin Endocrinol Metab 2004;89:3821–3829.Google Scholar
  110. 110.
    Chengalvala M, Oh T, Roy AK. Selective androgen receptor modulators. Expert Opinion on Therapeutic Patents 2003;13:59–66.Google Scholar
  111. 111.
    Lui PY, Swerdloff RS, Veldhuis JD. The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations. J Clin Endocrniol Metab 2004;89:4789–4796.Google Scholar
  112. 112.
    Morley JE. Is the hormonal fountain of youth drying up? J Gerontol Med Sci 2004;59A:458–460.Google Scholar
  113. 113.
    Snyder PJ. Effects of age on testicular function and consequences of testosterone treatment. J Clin Endocrinol Metab. 2001;86:2369–2372.Google Scholar
  114. 114.
    Morley JE. The need for a men’s health initiative. J Gerontol Med Sci 2003;58A:614–617.Google Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • S. H. Tariq
    • 1
  • M. T. Haren
    • 1
  • M. J. Kim
    • 1
  • J. E. Morley
    • 1
    • 2
  1. 1.GRECC, VA Medical Center and Division of Geriatric MedicineSaint Louis UniversitySt. Louis
  2. 2.Division of Geriatric MedicineSaint Louis University School of MedicineSt. Louis

Personalised recommendations